Health Kick Podcast: Aroa sets sights on sales growth in FY25
Health & Biotech
share
Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.
In this episode Tim chats with Brian Ward, founder and CEO at Aroa Biosurgery (ASX:ARX).
Aroa was founded in 2008 by Veterinarian Surgeon Dr Ward and is committed to unlocking regenerative healing for everybody through its patented AROA ECM™ complex wound and tissue reconstruction products.
ARX reported strong quarterly results in the latest quarter and is forecasting to be cashflow positive in H2 FY25.
Like to tune in through another app? Just search for Health Kick Podcast with Tim Boreham and subscribe!
This podcast was developed in collaboration with Aroa Biosurgery, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.
